| NDC Code | 33332-115-10 |
|---|
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (33332-115-10) > 5 mL in 1 VIAL, MULTI-DOSE (33332-115-11) |
|---|
| Product NDC | 33332-115 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Afluria |
|---|
| Non-Proprietary Name | Influenza A Virus A/california/7/2009 X-181 (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/texas/50/2012 X-223 (h3n2) Antigen (propiolactone Inactivated), And Influenza B Virus B/massachusetts/2/2012 Bx-51b Antigen (propiolactone Inactivated) |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20110715 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125254 |
|---|
| Manufacturer | bioCSL Pty Ltd. |
|---|
| Substance Name | INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/SOUTH AUSTRALIA/55/2014 IVR-175 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (PROPIOLACTONE INACTIVATED) |
|---|
| Strength | 15; 15; 15 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL |
|---|
| Pharmacy Classes | Inactivated Influenza A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [CS],Influenza Vaccines [CS] |
|---|